Ho Viet H, Ross Merrick I, Prieto Victor G, Khaleeq Aisha, Kim Stella, Esmaeli Bita
Section of Ophthalmology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Arch Otolaryngol Head Neck Surg. 2007 Aug;133(8):820-6. doi: 10.1001/archotol.133.8.820.
To provide clinical details and long-term outcome data for a series of patients with eyelid or conjunctival melanoma or eyelid sebaceous cell carcinoma who underwent sentinel lymph node (SLN) biopsy.
Retrospective interventional case series with review of clinical records and pathologic specimens.
Tertiary comprehensive cancer center.
Twenty-five consecutive patients treated at 1 institution for eyelid or conjunctival melanoma or eyelid sebaceous cell carcinoma from December 2000 to October 2004.
Surgical removal of the eyelid or conjunctival tumor and SLN biopsy.
Local treatment modalities; lymphatic basins in which SLNs were identified; status of SLNs; false-negative rate; and long-term patterns of local recurrence, regional and distant metastasis, and survival.
Seven patients had conjunctival melanoma, 8 had eyelid-margin melanoma with a considerable palpebral conjunctival component, and 10 had eyelid sebaceous cell carcinoma. The SLNs were identified in all but 1 patient by using technetium Tc 99m sulfur colloid as a tracer. Intraoperatively, in 16 patients in whom blue dye was used in addition to technetium Tc 99m sulfur colloid during mapping, no SLN was blue. One patient with conjunctival melanoma and 1 patient with eyelid melanoma had a histologically positive SLN. Two patients with eyelid melanoma and 2 patients with eyelid sebaceous cell carcinoma had negative findings from SLN biopsy but developed recurrence in their regional lymph nodes during the follow-up period. Overall, during follow-up, 2 of 10 patients with sebaceous cell carcinoma (20%) and 5 of 15 patients with eyelid or conjunctival melanoma (33%) had regional lymph node metastasis. Four patients with melanoma who had regional metastasis also developed distant organ metastasis. Two patients with sebaceous cell carcinoma--1 with regional metastasis and 1 without--developed distant organ metastasis.
The detection of histologically positive SLNs in this series of patients may justify further study of SLN biopsy for high-risk patients with ocular adnexal melanoma or eyelid sebaceous cell carcinoma. The false-negative rate is higher than that reported for SLN biopsy at most other anatomic sites. Patients with negative findings from SLN biopsy still require careful long-term follow-up because they may develop regional or distant metastasis.
为一系列接受前哨淋巴结(SLN)活检的眼睑或结膜黑色素瘤或眼睑皮脂腺癌患者提供临床细节和长期预后数据。
回顾性干预病例系列,对临床记录和病理标本进行回顾。
三级综合癌症中心。
2000年12月至2004年10月期间在1家机构接受治疗的25例连续患者,均患有眼睑或结膜黑色素瘤或眼睑皮脂腺癌。
手术切除眼睑或结膜肿瘤并进行SLN活检。
局部治疗方式;发现SLN的淋巴引流区;SLN的状态;假阴性率;以及局部复发、区域和远处转移及生存的长期模式。
7例患者患有结膜黑色素瘤,8例患有睑缘黑色素瘤且伴有相当程度的睑结膜成分,10例患有眼睑皮脂腺癌。除1例患者外,其余所有患者均通过使用锝Tc 99m硫胶体作为示踪剂发现了SLN。术中,在16例在定位过程中除使用锝Tc 99m硫胶体外还使用了蓝色染料的患者中,没有SLN呈蓝色。1例结膜黑色素瘤患者和1例眼睑黑色素瘤患者的SLN组织学检查呈阳性。2例眼睑黑色素瘤患者和2例眼睑皮脂腺癌患者的SLN活检结果为阴性,但在随访期间区域淋巴结出现复发。总体而言,在随访期间,10例皮脂腺癌患者中有2例(20%)以及15例眼睑或结膜黑色素瘤患者中有5例(33%)发生了区域淋巴结转移。4例发生区域转移的黑色素瘤患者也出现了远处器官转移。2例皮脂腺癌患者——1例有区域转移,1例无区域转移——出现了远处器官转移。
在这一系列患者中发现组织学检查呈阳性的SLN可能证明有必要对高危眼附属器黑色素瘤或眼睑皮脂腺癌患者的SLN活检进行进一步研究。假阴性率高于大多数其他解剖部位SLN活检报告的假阴性率。SLN活检结果为阴性的患者仍需要仔细的长期随访,因为他们可能发生区域或远处转移。